Market:
Global freshwater is becoming increasingly scarce, but unconventional resources such as ground brackish water, seawater and industrial wastewater are costly to procure and operate. Active Membranes’ technology substantially reduces the cost and footprint of these processes. Because it can be applied to any membrane-based water treatment system, at any scale from household point-of-use to large commercial plants, the combined market opportunity exceeds $20B.Technology:
Active Membranes’ technology synthesizes an electrically conducting film on top of already formed membranes — a coating that can be applied to microfiltration, ultrafiltration, nanofiltration, reverse osmosis and membrane distillation systems. Initial offerings target the last two types, for water desalination and softening. Membranes are packaged as drop-in replacements for existing systems, enabling noninvasive retrofitting. Customers will then buy the company’s membranes to replace old ones or use new membranes in new plants.
Advantages:
- Prevents scaling and fouling
- Recovers more water
- Minimizes pretreatment requirements
- Less complex with smaller footprint
- Drop-in replacement for existing plant
Development Stage:
- Prototype
Select Publications:
- The future of fresh water is bright | UCLA Newsroom
Contact:
Website: activemembrane.comGraduated in 2024
Back to Top
Graduate Companies
- Active Membranes
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Avesta76 Therapeutics
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete.ai
- Craytex
- CytoLumina
- DARTS Sciences
- EarlyDx
- ElectroNucleics
- EP Dynamics
- FemtoDx
- Ferrologix
- Gradient Orthodontics
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Lookin, Inc.
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- Nanoarmor, LLC.
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Nuvola Technology
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Partillion Bioscience
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- Scarless Laboratories
- SELFA
- Sixal
- Spectradyne
- Symphony Biosciences
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- ViBo Health
- Vivibaba
- Westwood Bioscience
- Zenomics
- Back to Portfolio
